Health system partners and professionals, industry, academia and patients, have all been engaged in the development of the changes, which NICE says signals how it is ‘evolving alongside technological advances in healthcare and evidence to continue to deliver excellence for patients, the NHS and the life sciences industry’.
Professor Gillian Leng CBE, NICE Chief Executive, commented: “The changes that we are making will provide a robust foundation for our evaluations now and in the future and enable us to continue to lead the way in rapid, independent health technology assessments.
“But they are not the end of the story. In the short term, we will explore the impacts and benefits of the updated methods and processes. We need to ensure they are effectively implemented in order to realise the benefits for NICE, the NHS and the wider stakeholder community, as well as supporting the Government’s wider vision for life sciences.
“Going forward, NICE will adopt a more modular approach to updates to its methods and processes. This will enable us to be more agile and responsive, monitoring, reviewing and improving our methods and processes into the future, making sure they remain cutting edge as the healthcare landscape continues to evolve.”
Further information about the changes can be found on NICE’s website.
